Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Accounts Payables (2023 - 2025)

Guardian Pharmacy Services' Accounts Payables history spans 3 years, with the latest figure at $116.2 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 13.46% year-over-year to $116.2 million; the TTM value through Dec 2025 reached $116.2 million, up 13.46%, while the annual FY2025 figure was $116.2 million, 13.46% up from the prior year.
  • Accounts Payables for Q4 2025 was $116.2 million at Guardian Pharmacy Services, down from $121.7 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $121.7 million in Q3 2025 and bottomed at $85.6 million in Q4 2023.
  • The 3-year median for Accounts Payables is $105.0 million (2025), against an average of $105.6 million.
  • The largest annual shift saw Accounts Payables grew 19.65% in 2024 before it increased 13.46% in 2025.
  • A 3-year view of Accounts Payables shows it stood at $85.6 million in 2023, then grew by 19.65% to $102.4 million in 2024, then rose by 13.46% to $116.2 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Accounts Payables are $116.2 million (Q4 2025), $121.7 million (Q3 2025), and $105.0 million (Q2 2025).